Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NephroGenex, Inc. | 13,740 | reported | 30 Apr 2015 | tx 2+16,816 |
| TENAX THERAPEUTICS, INC. | 5,000 | reported | 10 Jun 2021 | tx 6+32,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2021 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 5,000 | 0.00 USD | deriv |
| 01 May 2020 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 500 | 0.00 USD | deriv |
| 01 May 2018 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 500 | 0.00 USD | deriv |
| 21 Nov 2016 | OTHER | TENAX THERAPEUTICS, INC. | 7,000 | 1.51 USD | |
| 02 Feb 2016 | PURCHASE | TENAX THERAPEUTICS, INC. | 5,100 | 2.68 USD | |
| 03 Feb 2016 | PURCHASE | TENAX THERAPEUTICS, INC. | 13,900 | 2.65 USD | |
| 30 Apr 2015 | GRANT_AWARD | NephroGenex, Inc. | 13,740 | 0.00 USD | deriv |
| 15 May 2014 | GRANT_AWARD | NephroGenex, Inc. | 3,076 | 0.00 USD | deriv |